Home » Topics » BioWorld Asia

BioWorld Asia
RSS

Germany Backs China's Biotech International Exhibition

Feb. 25, 1998

EU Advisory Panel On Ethics Formed With Lenoir As Chairman

Feb. 25, 1998

Amrad Acquires Diagnostic Firm For A$50M In Cash, Stock

Feb. 25, 1998

HIV Drug Developer Frustrated; Pursuing Studies In China

Feb. 25, 1998

Peptech Making Changes; Returning To Australia

Feb. 25, 1998

Lilly To Pay Xenova $35M For Heart Attack Drug

Feb. 25, 1998

Gene Found That Keeps Female Embryos Female

Feb. 25, 1998

Genset's Revenues Double; But R&D Spending Widens '97 Loss

Feb. 25, 1998

Canadian Biotech Groups Merge To Form National Body

Feb. 25, 1998

Scientists Report Progress In Gene Disease Research

Feb. 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...